Marken (Formerly known as Marken Time Critical) Opens Branch Office In Seoul, South Korea
Published: May 25, 2012
RESEARCH TRIANGLE PARK, N.C., May 25, 2012 /PRNewswire/ -- Marken announced today that it has opened its first office in South Korea. The office will manage customer service operations and offer local service to its customers who currently operate in the South Korea. Marken currently operates in the country through its partners, managing thousands of shipments per year into and out of the country. This new office has been created recognizing that Korea represents a large and growing base of clinical trials, a growing number of pharmaceutical companies and an impressive number of pharmaceutical manufacturing centers. The new office is managed by Ms. Linda Kim, a specialist in clinical logistics with deep experience in the pharmaceutical services industry.
"We are pleased to finally have a permanent location in Seoul," said Wes Wheeler, Marken's Chief Executive. "We have recruited Linda Kim to manage the customer service operations, manage our suppliers and partners in the country and establish Marken's name as an important international supply chain services company for the pharmaceutical community. We expect to see continued growth in clinical trials in Korea but more importantly we see an opportunity to help our clients with time and temperature sensitive drug product and active ingredient which are biologically manufactured."
The contact details for the new office are:
Marken Korea Ltd.
10F, Kyobo Securities Bldg, 26-4, Youido-dong
Seoul, 150-737, Korea
Marken is the leading global clinical supply chain service provider dedicated 100% to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.